| mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
| mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
1 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
1 |
| mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
1 |
| mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.0018 |
1 |